Building upon our prior findings that BSTJF ameliorates PCOS via Sirtuin 3 mediated mitochondrial oxidative stress regulation [16], this study delineates its therapeutic action through NADPH oxidase-dependent redox dysregulation. This evidence concerns the gene FMO5 and polycystic ovary syndrome.